drugset

drugset / Trial / NCT00629980

Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis

NCT00629980 ↗

Phase 4 Completed 60 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.

Timeline

Start: 2008-02
Primary completion: 2008-09
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Azithromycin	Small molecule	—	Other

Indications